annual shareholders equity:
$675.29M+$338.62M(+100.58%)Summary
- As of today (July 1, 2025), PTGX annual stockholders equity is $675.29 million, with the most recent change of +$338.62 million (+100.58%) on December 31, 2024.
- During the last 3 years, PTGX annual shareholders equity has risen by +$375.27 million (+125.08%).
- PTGX annual shareholders equity is now at all-time high.
Performance
PTGX Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$689.05M+$13.76M(+2.04%)Summary
- As of today (July 1, 2025), PTGX quarterly stockholders equity is $689.05 million, with the most recent change of +$13.76 million (+2.04%) on March 1, 2025.
- Over the past year, PTGX quarterly shareholders equity has increased by +$128.61 million (+22.95%).
- PTGX quarterly shareholders equity is now at all-time high.
Performance
PTGX quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PTGX Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.6% | +22.9% |
| 3 y3 years | +125.1% | +128.3% |
| 5 y5 years | +744.5% | +999.6% |
PTGX Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +213.2% | at high | +219.6% |
| 5 y | 5-year | at high | +744.5% | at high | +311.4% |
| alltime | all time | at high | +8388.9% | at high | +7080.6% |
PTGX Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $689.05M(+2.0%) |
| Dec 2024 | $675.29M(+100.6%) | $675.29M(+27.0%) |
| Sep 2024 | - | $531.91M(-1.7%) |
| Jun 2024 | - | $541.32M(-3.4%) |
| Mar 2024 | - | $560.44M(+66.5%) |
| Dec 2023 | $336.68M(+56.2%) | $336.68M(+11.4%) |
| Sep 2023 | - | $302.15M(+2.7%) |
| Jun 2023 | - | $294.07M(+36.0%) |
| Mar 2023 | - | $216.17M(+0.3%) |
| Dec 2022 | $215.61M(-28.1%) | $215.61M(-11.5%) |
| Sep 2022 | - | $243.62M(-9.1%) |
| Jun 2022 | - | $267.98M(-11.2%) |
| Mar 2022 | - | $301.78M(+0.6%) |
| Dec 2021 | $300.02M(+7.3%) | $300.02M(-9.0%) |
| Sep 2021 | - | $329.66M(-7.8%) |
| Jun 2021 | - | $357.45M(+37.8%) |
| Mar 2021 | - | $259.33M(-7.3%) |
| Dec 2020 | $279.61M | $279.61M(+64.9%) |
| Sep 2020 | - | $169.59M(+1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $167.49M(+167.3%) |
| Mar 2020 | - | $62.67M(-21.6%) |
| Dec 2019 | $79.96M(-28.9%) | $79.96M(-16.1%) |
| Sep 2019 | - | $95.36M(+13.1%) |
| Jun 2019 | - | $84.32M(-16.4%) |
| Mar 2019 | - | $100.83M(-10.4%) |
| Dec 2018 | $112.52M(-6.7%) | $112.52M(-9.2%) |
| Sep 2018 | - | $123.96M(+15.1%) |
| Jun 2018 | - | $107.66M(-6.1%) |
| Mar 2018 | - | $114.62M(-5.0%) |
| Dec 2017 | $120.63M(+37.8%) | $120.63M(+108.6%) |
| Sep 2017 | - | $57.84M(-5.2%) |
| Jun 2017 | - | $61.03M(-18.5%) |
| Mar 2017 | - | $74.89M(-14.5%) |
| Dec 2016 | $87.56M(+812.4%) | $87.56M(-10.2%) |
| Sep 2016 | - | $97.49M(+377.8%) |
| Jun 2016 | - | $20.41M(-22.6%) |
| Mar 2016 | - | $26.38M(+174.9%) |
| Dec 2015 | $9.60M(+20.6%) | $9.60M |
| Dec 2014 | $7.96M | - |
FAQ
- What is Protagonist Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual shareholders equity year-on-year change?
- What is Protagonist Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly shareholders equity year-on-year change?
What is Protagonist Therapeutics annual stockholders equity?
The current annual shareholders equity of PTGX is $675.29M
What is the all time high annual shareholders equity for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual stockholders equity is $675.29M
What is Protagonist Therapeutics annual shareholders equity year-on-year change?
Over the past year, PTGX annual stockholders equity has changed by +$338.62M (+100.58%)
What is Protagonist Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of PTGX is $689.05M
What is the all time high quarterly shareholders equity for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly stockholders equity is $689.05M
What is Protagonist Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, PTGX quarterly stockholders equity has changed by +$128.61M (+22.95%)